All News

UK biotech Phynova makes a business out of developing traditional medicines, but when it comes to raising money it is pioneering a new, low-cost route to American investors.

Drug companies have lost confidence in the UK as a place to do business, according to research by two leading industry bodies.

A new €80 million fund has been set up by the European Commission to boost energy efficiency and renewables and help developing countries combat climate change.

There was an unprecedented number of cybersquatting cases in 2007, according to the latest statistics from the World Intellectual Property Organisation.

Financing high-tech start-ups is not getting any easier, but a pioneering UK biotech may have an escape route